Healthia Past Earnings Performance
Past criteria checks 2/6
Healthia has been growing earnings at an average annual rate of 28.5%, while the Healthcare industry saw earnings growing at 15.3% annually. Revenues have been growing at an average rate of 35.3% per year. Healthia's return on equity is 5.4%, and it has net margins of 2.2%.
Key information
28.5%
Earnings growth rate
40.5%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 35.3% |
| Return on equity | 5.4% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Healthia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 253 | 5 | 12 | 0 |
| 31 Mar 23 | 242 | 3 | 11 | 0 |
| 31 Dec 22 | 232 | 1 | 11 | 0 |
| 30 Sep 22 | 216 | -1 | 10 | 0 |
| 30 Jun 22 | 200 | -3 | 10 | 0 |
| 31 Mar 22 | 184 | -2 | 9 | 0 |
| 31 Dec 21 | 168 | 0 | 9 | 0 |
| 30 Sep 21 | 152 | 3 | 8 | 0 |
| 30 Jun 21 | 137 | 5 | 7 | 0 |
| 31 Mar 21 | 121 | 6 | 6 | 0 |
| 31 Dec 20 | 105 | 7 | 5 | 0 |
| 30 Sep 20 | 96 | 5 | 4 | 0 |
| 30 Jun 20 | 87 | 3 | 4 | 0 |
| 31 Mar 20 | 83 | 1 | 6 | 0 |
| 31 Dec 19 | 79 | 0 | 7 | 0 |
| 30 Sep 19 | 72 | 0 | 8 | 0 |
| 30 Jun 19 | 65 | -1 | 9 | 0 |
| 31 Mar 19 | 57 | -2 | 8 | 0 |
| 31 Dec 18 | 48 | -3 | 7 | 0 |
| 30 Sep 18 | 41 | -2 | 6 | 0 |
| 30 Jun 18 | 34 | -2 | 5 | 0 |
| 30 Jun 17 | 67 | 4 | 7 | 0 |
| 30 Jun 16 | 67 | 4 | 7 | 0 |
Quality Earnings: HE3 has a large one-off loss of A$6.2M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: HE3 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HE3 has become profitable over the past 5 years, growing earnings by 28.5% per year.
Accelerating Growth: HE3 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HE3 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.1%).
Return on Equity
High ROE: HE3's Return on Equity (5.4%) is considered low.